"Slingshot represents an opportunity to bridge the gap between academic innovation and clinical development of a novel ...

Syncona Shs GBP (GB:SYNC) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top StocksMake ...

Syncona has launched Slingshot Therapeutics with an initial $15 million investment through its Syncona Accelerator initiative ...

Syncona Ltd, (“Syncona”) a leading life science investor focused on creating, building and scaling global leaders in life science, today announces that it has launched a new portfolio company ...

(Alliance News) - Syncona Ltd on Thursday said it launched a new portfolio company as it reported a fall in net asset value, citing a weaker US dollar. The life science investor said net asset ...

(Sharecast News) - Syncona announced the launch of Slingshot Therapeutics, a new portfolio company and accelerator dedicated to developing early-stage life science programs sourced from academia ...

Fintel reports that on November 18, 2024, Goldman Sachs upgraded their outlook for Autolus Therapeutics plc - Depositary ...

Burberry Group continued to rally on Friday, a day after announcing a sweeping turnaround plan to save £40m and arrest its sales slump. Landscaping materials group Marshalls led the risers, while ...

It said Slingshot would remain wholly owned by Syncona, offering a capital-efficient and centralised structure to drive multiple preclinical projects towards clinical development. Slingshot’s ...